Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Vazquez

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cytotherapy|June 2, 2018
Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guidelineJesús Vaquero, Mercedes Zurita, Miguel A Rico, et al.
AMB Express|September 28, 2024
Metagenomic analyses of a consortium for the bioremediation of hydrocarbons polluted soilsEmiliana Pandolfo, David Durán-Wendt, Ruben Martínez-Cuesta, et al.
Cytotherapy|May 23, 2018
Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyeliaJesús Vaquero, Mercedes Zurita, Miguel A Rico, et al.
Journal of Proteomics|April 23, 2026
The proteomics analysis of mitochondria-enriched fractions reveals alteration of key mitochondrial pathways in breast cancer cell linesHersson David Vazquez-Narváez, María Luisa Labra-Barrios, Emmanuel Ríos-Castro, et al.
European Urology Open Science|May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 StudyMagnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cytotherapy|June 2, 2018
Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guidelineJesús Vaquero, Mercedes Zurita, Miguel A Rico, et al.
AMB Express|September 28, 2024
Metagenomic analyses of a consortium for the bioremediation of hydrocarbons polluted soilsEmiliana Pandolfo, David Durán-Wendt, Ruben Martínez-Cuesta, et al.
Cytotherapy|May 23, 2018
Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyeliaJesús Vaquero, Mercedes Zurita, Miguel A Rico, et al.
Journal of Proteomics|April 23, 2026
The proteomics analysis of mitochondria-enriched fractions reveals alteration of key mitochondrial pathways in breast cancer cell linesHersson David Vazquez-Narváez, María Luisa Labra-Barrios, Emmanuel Ríos-Castro, et al.
European Urology Open Science|May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 StudyMagnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Pageof 3